- Generic name
- Tofacitinib
- Strength
- 5 mg
- Dosage form
- Tablet
- Manufactured by
- Opsonin Pharma Limited
Xelnib 5 Tablet
About Xelnib 5 Tablet
The tablet Xelnib 5 contains Tofacitinib and is made by Opsonin Pharma Limited. It may be taken alone or with methotrexate or other nonbiologic disease-modifying antirheumatic drugs.
There are 13 brands of Tofacitinib listed in Bangladesh. The lowest listed price is Tofacit 5 mg Tablet at ৳ 30.00 per unit.
What is Xelnib 5 Tablet?
The tablet Xelnib 5 contains Tofacitinib and is made by Opsonin Pharma Limited. It is prescribed for adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. Tofacitinib belongs to a group of medicines called immunosuppressants. The dose and course are decided by the doctor.
Uses of Xelnib 5
It may be taken alone or with methotrexate or other nonbiologic disease-modifying antirheumatic drugs. Xelnib 5 is used for adults with moderately to severely active rheumatoid arthritis whose earlier treatment with methotrexate did not work well enough or was not tolerated. Your doctor will decide if it is suitable for you.
How to use Xelnib 5
Swallow the tablet whole with water; do not crush or chew it. Xelnib 5 is taken by mouth. If a dose is missed, ask the doctor or pharmacist for advice. Do not change the dose or stop treatment on your own. The dose and course are decided by your doctor based on your condition and other medicines you take.
Side effects of Xelnib 5
Because Tofacitinib affects the immune system, serious infections can occur. Common side effects reported with Tofacitinib include upper respiratory tract infections, headache, diarrhoea and nasopharyngitis (cold-like symptoms). Ask your doctor or pharmacist about what to watch for. Contact your doctor if you notice anything unusual after taking it.
Safety and precautions
It may increase the risk of gastrointestinal perforations, so use with caution if you are at risk. It is not known if it passes into breast milk; discuss breastfeeding with your doctor. Do not start it if certain blood counts are low; your doctor will check. Tell your doctor about all the other medicines you take.
Frequently asked questions
What does Xelnib 5 treat?
It may be taken alone or with methotrexate or other nonbiologic disease-modifying antirheumatic drugs. Xelnib 5 is used for adults with moderately to severely active rheumatoid arthritis whose earlier treatment with methotrexate did not work well enough or was not tolerated.
How is Xelnib 5 used?
Swallow the tablet whole with water; do not crush or chew it. Xelnib 5 is taken by mouth.
What should I watch for while using Xelnib 5?
Because Tofacitinib affects the immune system, serious infections can occur. Common side effects reported with Tofacitinib include upper respiratory tract infections, headache, diarrhoea and nasopharyngitis (cold-like symptoms).
Can I use Xelnib 5 in pregnancy or while breastfeeding?
It may increase the risk of gastrointestinal perforations, so use with caution if you are at risk. It is not known if it passes into breast milk; discuss breastfeeding with your doctor.
Indications
Psoriatic Arthritis: Tofacitinib is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease-modifying antirheumatic drugs (DMARDs).
Ulcerative Colitis: Tofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).
Pharmacology
Tofacitinib is a partial and reversible janus kinase (JAK) inihibitor that will prevent the body from responding to cytokine signals. By inhibiting JAKs, tofacitinib prevents the phosphorylation and activation of STATs. The JAK-STAT signalling pathway is involved in the transcription of cells involved in hematopoiesis, and immune cell function. Tofacitinib works therapeutically by inhibiting the JAK-STAT pathway to decrease the inflammatory response. However, there is evidence to suggest that it may also achieve efficacy via other pathways as well.
Dosage & Administration
Psoriatic Arthritis (in combination with nonbiologic DMARDs): Tofacitinib 5 mg twice daily or Tofacitinib 11 mg once daily. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment is Tofacitinib 5 mg once daily.
Ulcerative Colitis: Tofacitinib 10 mg twice daily for at least 8 weeks; then 5 or 10 mg twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to maintain response.
Interaction
- Potent inhibitors of Cytochrome P450 3A4 (CYP3A4) (e.g., Ketoconazole)
- Recommended dose is Tofacitinib 5 mg once daily: One or more concomitant medications that result in both moderate inhibition of CYP3A4 and potent inhibition of CYP2C19 (e.g., fluconazole)
- Recommended dose is Tofacitinib 5 mg once daily Potent CYP inducers (e.g.Rifampin): May result in loss of or reduced clinical response.
Side Effects
Pregnancy & Lactation
It is not known whether Tofacitinib is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from Tofacitinib, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug for the mother
Precautions & Warnings
- Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections.
- Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.
- Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.
- Immunizations: Live vaccines: Avoid use with Tofacitinib.
- Do not initiate Tofacitinib if absolute lymphocyte count <500 cells/mm3, an absolute neutrophil count (ANC) <1000 cells/mm3 or hemoglobin <9 gm/dL.
Storage Conditions
Alternative brands of Tofacitinib
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.